Nifty
Sensex
:
:
25800.60
83919.71
286.30 (1.12%)
897.96 (1.08%)

Healthcare Services - Diagnostic

Rating :
72/99

BSE: 539524 | NSE: LALPATHLAB

2006.00
20-Nov-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1950
  •  2028.2
  •  1940
  •  1963.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  264951
  •  533138967.3
  •  2079
  •  1272.6

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 33,679.70
  • 57.72
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 32,599.80
  • 1.02%
  • 12.27

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.93%
  • 0.40%
  • 5.29%
  • FII
  • DII
  • Others
  • 18.73%
  • 21.14%
  • 1.51%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.72
  • 5.77
  • 7.46

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.66
  • 6.89
  • 5.13

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.56
  • 7.92
  • 12.16

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 61.00
  • 61.23
  • 56.48

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.14
  • 12.23
  • 11.55

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.47
  • 32.43
  • 31.12

Earnings Forecasts:

(Updated: 14-11-2026)
Description
2026
2027
2028
2029
Adj EPS
30.24
38.83
45.7
53.67
P/E Ratio
66.34
51.66
43.89
37.38
Revenue
2762.91
3264.02
3756.88
4288.83
EBITDA
782.52
972.8
1128.6
1301.51
Net Income
504.78
654.35
769.79
905.85
ROA
17.22
19.21
19.88
20.67
P/B Ratio
13.35
11.61
10.01
8.63
ROE
21.57
24.08
24.65
24.94
FCFF
515.6
698.3
811.82
940.96
FCFF Yield
1.58
2.14
2.49
2.88
Net Debt
-1133.13
-1418.12
-1878.67
-2496.9
BVPS
150.21
172.74
200.41
232.38

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 26
Sep 25
Var%
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Net Sales
873.90
730.60
19.61%
797.70
669.80
19.10%
702.70
602.60
16.61%
659.80
596.70
10.57%
Expenses
593.70
506.50
17.22%
550.20
477.50
15.23%
515.90
433.60
18.98%
480.50
442.70
8.54%
EBITDA
280.20
224.10
25.03%
247.50
192.30
28.71%
186.80
169.00
10.53%
179.30
154.00
16.43%
EBIDTM
32.06%
30.67%
31.03%
28.71%
26.58%
28.05%
27.17%
25.81%
Other Income
34.30
24.80
38.31%
31.90
28.10
13.52%
24.00
25.80
-6.98%
24.40
25.10
-2.79%
Interest
7.00
4.80
45.83%
6.30
4.70
34.04%
6.10
5.00
22.00%
7.20
5.30
35.85%
Depreciation
46.90
40.50
15.80%
44.40
34.60
28.32%
44.60
36.40
22.53%
42.10
35.50
18.59%
PBT
260.60
203.60
28.00%
228.70
181.10
26.28%
160.10
153.40
4.37%
124.30
138.30
-10.12%
Tax
66.60
51.40
29.57%
58.20
47.10
23.57%
27.90
-2.10
-
32.90
40.20
-18.16%
PAT
194.00
152.20
27.46%
170.50
134.00
27.24%
132.20
155.50
-14.98%
91.40
98.10
-6.83%
PATM
22.20%
20.83%
21.37%
20.01%
18.81%
25.80%
13.85%
16.44%
EPS
11.45
8.99
27.36%
10.11
7.90
27.97%
7.83
9.26
-15.44%
5.40
5.78
-6.57%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
3,034.10
2,762.91
2,461.39
2,226.64
2,016.88
2,087.41
1,581.27
1,330.36
1,203.42
1,056.92
912.38
Net Sales Growth
16.71%
12.25%
10.54%
10.40%
-3.38%
32.01%
18.86%
10.55%
13.86%
15.84%
 
Cost Of Goods Sold
577.50
534.62
481.46
451.42
447.15
502.25
397.26
298.70
262.35
226.03
197.08
Gross Profit
2,456.60
2,228.29
1,979.93
1,775.22
1,569.73
1,585.16
1,184.01
1,031.65
941.07
830.89
715.30
GP Margin
80.97%
80.65%
80.44%
79.73%
77.83%
75.94%
74.88%
77.55%
78.20%
78.61%
78.40%
Total Expenditure
2,140.30
1,980.39
1,765.80
1,617.40
1,527.05
1,526.68
1,144.99
986.78
909.76
792.92
674.86
Power & Fuel Cost
-
28.25
27.16
26.18
25.91
22.11
18.62
16.74
15.74
15.32
13.58
% Of Sales
-
1.02%
1.10%
1.18%
1.28%
1.06%
1.18%
1.26%
1.31%
1.45%
1.49%
Employee Cost
-
503.26
455.78
424.57
376.52
364.94
273.70
242.64
208.29
180.75
152.01
% Of Sales
-
18.21%
18.52%
19.07%
18.67%
17.48%
17.31%
18.24%
17.31%
17.10%
16.66%
Manufacturing Exp.
-
530.86
468.05
423.24
385.55
361.63
257.16
224.87
196.24
166.22
137.24
% Of Sales
-
19.21%
19.02%
19.01%
19.12%
17.32%
16.26%
16.90%
16.31%
15.73%
15.04%
General & Admin Exp.
-
327.60
281.88
236.97
233.04
229.30
157.20
164.31
188.71
174.12
147.72
% Of Sales
-
11.86%
11.45%
10.64%
11.55%
10.98%
9.94%
12.35%
15.68%
16.47%
16.19%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
55.80
51.46
55.02
58.88
46.45
41.05
39.51
38.43
30.48
0.00
% Of Sales
-
2.02%
2.09%
2.47%
2.92%
2.23%
2.60%
2.97%
3.19%
2.88%
2.98%
EBITDA
893.80
782.52
695.59
609.24
489.83
560.73
436.28
343.58
293.66
264.00
237.52
EBITDA Margin
29.46%
28.32%
28.26%
27.36%
24.29%
26.86%
27.59%
25.83%
24.40%
24.98%
26.03%
Other Income
114.60
101.27
93.43
69.17
41.72
52.55
51.33
55.05
45.95
31.22
27.54
Interest
26.60
22.80
22.30
29.36
37.53
30.18
16.00
15.31
0.84
0.84
0.70
Depreciation
178.00
161.80
141.92
143.60
150.19
108.11
77.20
72.81
38.22
33.06
27.54
PBT
773.70
699.18
624.80
505.45
343.83
474.98
394.41
310.50
300.55
261.31
236.82
Tax
185.60
159.33
132.55
143.16
102.75
124.69
97.93
82.92
100.08
89.56
81.23
Tax Rate
23.99%
23.81%
21.21%
28.32%
29.88%
26.25%
24.83%
26.71%
33.30%
34.27%
34.30%
PAT
588.10
504.78
487.14
357.73
238.85
344.83
291.62
225.94
199.18
170.73
154.59
PAT before Minority Interest
583.60
509.75
492.25
362.29
241.08
350.29
296.48
227.59
200.47
171.75
155.59
Minority Interest
-4.50
-4.97
-5.11
-4.56
-2.23
-5.46
-4.86
-1.65
-1.29
-1.02
-1.00
PAT Margin
19.38%
18.27%
19.79%
16.07%
11.84%
16.52%
18.44%
16.98%
16.55%
16.15%
16.94%
PAT Growth
8.95%
3.62%
36.18%
49.77%
-30.73%
18.25%
29.07%
13.44%
16.66%
10.44%
 
EPS
35.05
30.08
29.03
21.32
14.23
20.55
17.38
13.46
11.87
10.17
9.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
2,508.14
2,172.72
1,849.28
1,666.30
1,501.61
1,245.06
1,032.81
945.50
787.85
595.52
Share Capital
167.56
83.59
83.48
83.37
83.34
83.34
83.34
83.34
83.33
83.07
Total Reserves
2,274.53
2,032.48
1,714.65
1,524.67
1,359.98
1,121.91
916.58
834.12
686.58
503.91
Non-Current Liabilities
66.56
21.34
62.16
175.84
272.66
83.01
70.12
-20.25
-8.96
-6.41
Secured Loans
0.00
0.00
0.00
83.33
166.67
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.13
0.12
0.00
0.00
0.00
0.00
Long Term Provisions
2.65
1.95
1.61
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
450.62
402.35
463.58
469.75
499.99
274.29
227.31
138.30
115.96
84.84
Trade Payables
180.60
167.05
186.57
156.10
147.38
144.13
117.73
79.80
65.45
52.38
Other Current Liabilities
189.17
186.31
227.46
214.02
226.98
108.00
94.03
40.58
40.38
25.37
Short Term Borrowings
0.00
0.00
0.00
70.00
95.42
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
80.85
48.99
49.55
29.63
30.20
22.16
15.55
17.93
10.13
7.09
Total Liabilities
3,058.46
2,630.17
2,411.10
2,345.14
2,309.72
1,633.32
1,351.46
1,069.03
898.64
676.39
Net Block
1,223.57
1,134.99
1,193.83
1,305.06
1,368.81
447.26
413.02
208.66
207.52
152.43
Gross Block
2,146.43
1,903.54
1,828.44
1,807.22
1,726.23
683.53
574.29
301.66
263.71
180.09
Accumulated Depreciation
922.86
768.55
634.62
502.16
357.42
236.27
161.27
93.00
56.19
27.66
Non Current Assets
1,491.97
1,266.66
1,284.41
1,372.05
1,434.56
488.14
458.81
255.41
275.61
209.83
Capital Work in Progress
6.53
3.48
5.65
4.94
15.00
9.61
11.38
3.44
9.56
17.51
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
33.32
26.66
31.26
35.21
39.89
27.14
20.38
16.95
16.26
17.79
Other Non Current Assets
195.76
68.18
19.97
26.84
10.86
4.13
14.03
26.36
42.27
22.09
Current Assets
1,566.49
1,363.51
1,126.70
973.09
875.15
1,145.17
892.65
813.63
623.02
466.56
Current Investments
422.59
326.70
113.78
149.94
65.46
59.30
164.28
184.78
144.80
106.08
Inventories
43.85
36.13
37.31
33.81
52.54
42.56
56.96
28.54
27.34
17.91
Sundry Debtors
110.69
88.12
77.40
70.82
85.39
66.70
51.39
53.22
41.16
41.80
Cash & Bank
909.53
838.68
830.31
665.41
617.59
926.03
569.12
490.24
313.51
239.51
Other Current Assets
79.82
50.88
47.89
34.38
54.17
50.58
50.91
56.85
96.22
61.25
Short Term Loans & Adv.
26.45
23.00
20.01
18.72
20.34
18.82
21.38
32.46
80.76
48.55
Net Current Assets
1,115.88
961.16
663.12
503.33
375.16
870.88
665.34
675.33
507.06
381.72
Total Assets
3,058.46
2,630.17
2,411.11
2,345.14
2,309.71
1,633.31
1,351.46
1,069.04
898.63
676.39

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
635.61
568.88
535.33
456.03
446.69
398.15
283.89
218.54
197.06
171.31
PBT
669.09
624.80
505.45
343.83
474.98
394.41
310.50
300.55
261.31
155.59
Adjustment
115.28
106.86
126.18
183.16
118.45
68.77
54.69
12.96
20.86
94.46
Changes in Working Capital
26.62
1.12
35.74
35.48
-16.71
36.67
12.17
9.30
8.93
-8.13
Cash after chg. in Working capital
810.99
732.78
667.37
562.46
576.72
499.85
377.36
322.81
291.10
241.92
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-175.38
-163.90
-132.03
-106.43
-130.03
-101.70
-93.47
-104.28
-94.03
-70.61
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-421.86
-303.16
-24.27
-287.31
-449.25
-212.02
-26.11
-99.74
-172.28
-137.11
Net Fixed Assets
-242.13
-71.33
-931.85
-59.00
-152.56
-68.77
-195.23
-29.28
-71.11
146.62
Net Investments
-97.61
-202.42
1,000.19
-151.60
-891.20
82.16
-38.73
-40.48
-39.28
-60.10
Others
-82.12
-29.41
-92.61
-76.71
594.51
-225.41
207.85
-29.98
-61.89
-223.63
Cash from Financing Activity
-263.57
-334.03
-413.86
-283.18
136.45
-138.56
-190.44
-55.26
12.51
-32.26
Net Cash Inflow / Outflow
-49.83
-68.31
97.20
-114.46
133.90
47.58
67.33
63.54
37.30
1.94
Opening Cash & Equivalents
292.63
360.93
263.73
378.19
244.30
196.72
129.39
65.85
28.55
26.61
Closing Cash & Equivalent
242.80
292.63
360.93
263.73
378.20
244.30
196.72
129.39
65.85
28.55

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
145.75
126.57
107.70
192.88
173.17
144.61
119.97
110.08
92.39
70.66
ROA
17.92%
19.53%
15.23%
10.36%
17.77%
19.87%
18.81%
20.38%
21.81%
24.13%
ROE
22.37%
25.15%
21.27%
15.80%
26.45%
26.89%
23.74%
23.76%
25.32%
28.45%
ROCE
29.56%
31.53%
27.89%
20.34%
32.67%
36.03%
32.94%
34.78%
37.90%
43.07%
Fixed Asset Turnover
1.36
1.32
1.22
1.14
1.73
2.51
3.04
4.26
4.76
3.54
Receivable days
13.13
12.27
12.15
14.14
13.30
13.63
14.35
14.31
14.32
15.62
Inventory Days
5.28
5.45
5.83
7.81
8.31
11.49
11.73
8.47
7.81
6.49
Payable days
118.67
134.04
138.53
123.86
105.92
120.30
41.84
36.52
34.38
32.53
Cash Conversion Cycle
-100.26
-116.32
-120.56
-101.91
-84.31
-95.18
-15.76
-13.73
-12.25
-10.42
Total Debt/Equity
0.00
0.00
0.05
0.15
0.24
0.00
0.00
0.00
0.00
0.00
Interest Cover
30.35
29.01
18.22
10.16
16.74
25.65
21.28
359.22
311.72
340.29

News Update:


  • Dr. Lal Pathlabs - Quarterly Results
    5th Nov 2026, 00:00 AM

    Read More
  • Dr. Lal Pathlabs’ arm acquires remaining 30% stake in Centrapath Labs
    14th Oct 2026, 14:11 PM

    Pursuant to the aforesaid acquisition, CPL has become a Wholly Owned Subsidiary of PUPL

    Read More
  • Dr. Lal Pathlabs makes further investment in PathLabs Unifiers
    12th Oct 2026, 15:30 PM

    The transaction value is not exceeding Rs 30.3 crore

    Read More
  • Dr. Lal PathLabs’ arm completes acquisition of 80% stake in SHL, Ghana
    28th Sep 2026, 12:20 PM

    Accordingly, SHL has become a step-down subsidiary of the company

    Read More
  • Dr. Lal PathLabs gets nod to acquire 70% stake in SN Genelab
    25th Sep 2026, 12:29 PM

    Post acquisition, SN Gene shall become a Subsidiary of the Company

    Read More
  • Dr. Lal Pathlabs’ arm completes subscription of 30% stake in Neuome Technologies
    28th Aug 2026, 11:14 AM

    Pursuant to completion of said subscription, Neuome has now become associate of the company

    Read More
  • Dr. Lal Pathlabs’ arm incorporates subsidiary company in Uzbekistan
    20th Aug 2026, 10:11 AM

    The objective of incorporation is to strengthen the group’s presence in Tashkent, Uzbekistan.

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.